AFX: What We Now Know
Author:
- 28 September 2011
- journal article
- Published by Wiley in Journal of Cutaneous Pathology
- Vol. 38 (11) , 853-856
Abstract
No abstract availableKeywords
This publication has 25 references indexed in Scilit:
- Diagnostic utility of low-affinity nerve growth factor receptor (P 75) immunostaining in atypical fibroxanthomaJournal of Cutaneous Pathology, 2011
- Myofibroblastic differentiation in atypical fibroxanthomas occurring on sun-exposed skin and in a burn scar: an ultrastructural and immunohistochemical studyJournal of Cutaneous Pathology, 2011
- Atypical fibroxanthoma showing diffuse staining for CD31Journal of Cutaneous Pathology, 2011
- Atypical Fibroxanthoma: A Histological and Immunohistochemical Review of 171 CasesThe American Journal of Dermatopathology, 2010
- CD10‐positive myxofibrosarcomas: a pitfall in the differential diagnosis of atypical fibroxanthomaJournal of Cutaneous Pathology, 2010
- CD10, p63 and CD99 expression in the differential diagnosis of atypical fibroxanthoma, spindle cell squamous cell carcinoma and desmoplastic melanomaJournal of Cutaneous Pathology, 2010
- Granular cell atypical fibroxanthoma: case report and review of the literatureJournal of Cutaneous Pathology, 2010
- Morphological and immunohistochemical characteristics of atypical fibroxanthoma with a special emphasis on potential diagnostic pitfalls: a reviewJournal of Cutaneous Pathology, 2010
- Diagnostic value of CD163 in cutaneous spindle cell lesionsJournal of Cutaneous Pathology, 2009
- Myxofibrosarcoma in the skinJournal of Cutaneous Pathology, 2008